Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients

Alkan A., Yasar A., Karci E., KÖKSOY E. B., Urun M., ÇAY ŞENLER F., ...Daha Fazla

SUPPORTIVE CARE IN CANCER, cilt.25, sa.1, ss.229-236, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1007/s00520-016-3409-6
  • Dergi Adı: SUPPORTIVE CARE IN CANCER
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.229-236
  • Anahtar Kelimeler: Severe drug interaction, Potentially inappropriate medication, Elderly, Beers Criteria, Geriatric oncology, Polypharmacy, OLDER-PEOPLE, POLYPHARMACY, PREVALENCE, ADULTS, CHEMOTHERAPY, TOXICITY, THERAPY, CARE
  • Ankara Üniversitesi Adresli: Evet

Özet

Due to more comorbidities, polypharmacy is common in elderly patients and drug interactions are inevitable. It is also challenging to treat an elderly patient with a diagnosis of cancer. Prevalence and clinical impacts of drug interactions and using potentially inappropriate medications (PIMs) have been studied in geriatric patients. However, these are not well defined in oncology practice. The purpose of this study is to define the prevalence of PIMs and severe drug interactions (SDIs) in elderly cancer patients and investigate the factors associated with them.